Literature DB >> 16718757

Functional dyspepsia and irritable bowel syndrome, are they different entities and does it matter?

Kok-Ann Gwee1, Andrew Seng Boon Chua.   

Abstract

A high prevalence of overlap between functional dyspepsia and irritable bowel syndrome has been consistently and universally reported. Recent studies demonstrating shared common pathophysiological disturbances including delayed gastric emptying and visceral hypersensitivity involving more than one region, suggest that these patients have a generalised rather than regional, disorder of the gut. Furthermore, a study of the natural history of dyspepsia suggests that with time, a substantial proportion will evolve into IBS. The recognition of IBS in dyspeptic patients has potentially profound therapeutic importance. It could help to reduce the risk of unnecessary cholecystectomy in IBS patients. The ability to appreciate the extent of involvement could allow us to address the disturbances more comprehensively, and thereby achieve greater patient satisfaction with their treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16718757      PMCID: PMC4130979          DOI: 10.3748/wjg.v12.i17.2708

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  40 in total

Review 1.  Unnecessary abdominal and back surgery in irritable bowel syndrome: time to stem the flood now?

Authors:  Nicholas J Talley
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

2.  Dyspepsia and dyspepsia subgroups: a population-based study.

Authors:  N J Talley; A R Zinsmeister; C D Schleck; L J Melton
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

3.  Gastric emptying and dyspeptic symptoms in the irritable bowel syndrome.

Authors:  H J van Wijk; A J Smout; L M Akkermans; J M Roelofs; O J ten Thije
Journal:  Scand J Gastroenterol       Date:  1992       Impact factor: 2.423

4.  Origin of chronic right upper quadrant pain.

Authors:  J G Kingham; A M Dawson
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

5.  Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide.

Authors:  F Narducci; G Bassotti; M T Granata; M A Pelli; M Gaburri; R Palumbo; A Morelli
Journal:  Dig Dis Sci       Date:  1986-03       Impact factor: 3.199

6.  Gastric emptying rate and small bowel transit time in patients with irritable bowel syndrome determined with 99mTc-labeled pellets and scintigraphy.

Authors:  O H Nielsen; T Gjørup; F N Christensen
Journal:  Dig Dis Sci       Date:  1986-12       Impact factor: 3.199

7.  Irritable bowel syndrome and surgery: a multivariable analysis.

Authors:  George F Longstreth; Janis F Yao
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

8.  Upper gastrointestinal and mental symptoms in the irritable bowel syndrome.

Authors:  J Svedlund; I Sjödin; G Dotevall; R Gillberg
Journal:  Scand J Gastroenterol       Date:  1985-06       Impact factor: 2.423

9.  Failure to demonstrate altered gastric emptying in irritable bowel syndrome.

Authors:  U Acharya; N Waite; P Howlett; A R Tanner; C L Smith
Journal:  Dig Dis Sci       Date:  1983-10       Impact factor: 3.199

10.  Site of pain from the irritable bowel.

Authors:  E T Swarbrick; J E Hegarty; L Bat; C B Williams; A M Dawson
Journal:  Lancet       Date:  1980-08-30       Impact factor: 79.321

View more
  17 in total

1.  Increased cholecystectomy rate in the laparoscopic era: a study of the potential causative factors.

Authors:  Peter Sipos; Osama Damrah
Journal:  Surg Endosc       Date:  2007-03-13       Impact factor: 4.584

2.  Identification of Individuals with Functional Dyspepsia With a Simple, Minimally Invasive Test: A Single Center Cohort Study of the Oral Capsaicin Test.

Authors:  Johann Hammer
Journal:  Am J Gastroenterol       Date:  2018-03-13       Impact factor: 10.864

Review 3.  Reassessment of functional dyspepsia: a topic review.

Authors:  Andrew Seng Boon Chua
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

4.  Analysis of the gastrointestinal symptoms of uninvestigated dyspepsia and irritable bowel syndrome.

Authors:  Kazutoshi Hori; Takayuki Matsumoto; Hiroto Miwa
Journal:  Gut Liver       Date:  2009-09-30       Impact factor: 4.519

5.  Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes.

Authors:  Ami D Sperber; Roy Dekel
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

6.  Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders.

Authors:  H Paula; M Grover; S L Halder; G R Locke; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2015-08-24       Impact factor: 3.598

7.  Recurrent symptoms after fundoplication with a negative pH study--recurrent reflux or functional heartburn?

Authors:  Sarah K Thompson; Wang Cai; Glyn G Jamieson; Alison Y Zhang; Jennifer C Myers; Zoe E Parr; David I Watson; Jenny Persson; Gerald Holtmann; Peter G Devitt
Journal:  J Gastrointest Surg       Date:  2008-08-20       Impact factor: 3.452

8.  Prevalence of irritable bowel syndrome and functional dyspepsia, overlapping symptoms, and associated factors in a general population of Bangladesh.

Authors:  Irin Perveen; Mufti Munsurar Rahman; Madhusudan Saha; Mohammad Masudur Rahman; Mohammad Quamrul Hasan
Journal:  Indian J Gastroenterol       Date:  2014-03-26

9.  Exploratory Study of Tegaserod for Dyspepsia in Women Receiving PPIs for Heartburn.

Authors:  Nimish Vakil; Farid Kianifard; Ivan Bottoli
Journal:  Arch Drug Inf       Date:  2008-12

10.  Systematic investigation of gastrointestinal diseases in China (SILC): validation of survey methodology.

Authors:  Xiaoyan Yan; Rui Wang; Yanfang Zhao; Xiuqiang Ma; Jiqian Fang; Hong Yan; Xiaoping Kang; Ping Yin; Yuantao Hao; Qiang Li; John Dent; Joseph Sung; Duowu Zou; Saga Johansson; Katarina Halling; Wenbin Liu; Jia He
Journal:  BMC Gastroenterol       Date:  2009-11-19       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.